biguanides has been researched along with Cholera Infantum in 13 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Excerpt | Relevance | Reference |
|---|---|---|
| " As an essential complication provoked by biguanides a lactic acidosis may be elicited which--though seldom occurring--then in most cases takes a fatal course." | 3.67 | [Drug-induced harm due to antidiabetics]. ( Verlohren, HJ, 1984) |
| " The most frequent adverse events with dulaglutide treatment were nasopharyngitis and gastrointestinal symptoms." | 2.80 | Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study. ( Araki, E; Imaoka, T; Inagaki, N; Oura, T; Takeuchi, M; Tanizawa, Y, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (76.92) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, E | 1 |
| Inagaki, N | 1 |
| Tanizawa, Y | 1 |
| Oura, T | 1 |
| Takeuchi, M | 1 |
| Imaoka, T | 1 |
| Yamasaki, Y | 1 |
| Kuroda, A | 1 |
| Kanazawa, A | 1 |
| Kawamori, R | 1 |
| Verlohren, HJ | 1 |
| Czyzyk, A | 1 |
| Stryjek-Kamińska, D | 1 |
| Tiercelin, A | 1 |
| Ito, T | 1 |
| Aarseth, S | 2 |
| Dats-Epshteĭn, MS | 1 |
| Bäbler, M | 1 |
| Schneider, T | 1 |
| Lopis, S | 1 |
| Petrides, P | 1 |
7 reviews available for biguanides and Cholera Infantum
| Article | Year |
|---|---|
[Adverse effect of biguanides].
Topics: Acidosis, Lactic; Biguanides; Diabetes Mellitus, Type 2; Gastrointestinal Diseases; Humans; Hypoglyc | 2002 |
[Adverse effects of insulin sensitisers and biguanides].
Topics: Acidosis, Lactic; Animals; Biguanides; Capillary Permeability; Chemical and Drug Induced Liver Injur | 2007 |
[Adverse effects and interactions of oral antidiabetics].
Topics: Administration, Oral; Biguanides; Diabetes Mellitus; Drug Interactions; Ethanol; Gastrointestinal Di | 1980 |
[Oral antidiabetics].
Topics: Acidosis; Biguanides; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Gastrointesti | 1972 |
[On the use of oral antidiabetic drugs].
Topics: Administration, Oral; Biguanides; Drug Interactions; Gastrointestinal Diseases; Half-Life; Humans; H | 1973 |
[Mechanism of the action of biquanid preparations and their use in diabetes mellitus in children].
Topics: Biguanides; Blood Glucose; Child; Diabetes Mellitus, Type 1; Drug Hypersensitivity; Fatty Acids, Non | 1973 |
[Oral antidiabetic drugs].
Topics: Biguanides; Diabetes Mellitus; Gastrointestinal Diseases; Humans; Hypoglycemic Agents; Islets of Lan | 1971 |
2 trials available for biguanides and Cholera Infantum
| Article | Year |
|---|---|
Efficacy and safety of once-weekly dulaglutide in combination with sulphonylurea and/or biguanide compared with once-daily insulin glargine in Japanese patients with type 2 diabetes: a randomized, open-label, phase III, non-inferiority study.
Topics: Aged; Biguanides; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Administration Schedul | 2015 |
HB419 (glibenclamide) in the treatment of diabetes mellitus.
Topics: Adult; Age Factors; Aged; Biguanides; Chlorpropamide; Clinical Trials as Topic; Diabetes Complicatio | 1969 |
4 other studies available for biguanides and Cholera Infantum
| Article | Year |
|---|---|
[Drug-induced harm due to antidiabetics].
Topics: Abnormalities, Drug-Induced; Acidosis; Biguanides; Bone Marrow; Cardiovascular Diseases; Chemical an | 1984 |
[Metoclopramide in gastrointestinal drug intolerance].
Topics: Biguanides; Drug Hypersensitivity; Gastrointestinal Diseases; Humans; Metoclopramide | 1976 |
[Oral antidiabetics].
Topics: Administration, Oral; Biguanides; Diabetes Mellitus; Gastrointestinal Diseases; Humans; Hypoglycemia | 1972 |
[Labile diabetes. Pathophysiology, clinical aspects, therapy].
Topics: Biguanides; Carbohydrate Metabolism; Cystic Fibrosis; Diabetes Mellitus; Diabetic Neuropathies; Gall | 1966 |